Navigation Links
NewCardio Leadership to Present Two Abstracts at ISCE Conference
Date:3/31/2009

ed in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit www.newcardio.com.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based on currently available information and assumptions made by management. Although we believe that the assumptions on which the forward-looking statements contained herein are based are reasonable, any of those assumptions could prove to be inaccurate given the inherent uncertainties as to the occurrence or nonoccurrence of future events. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including the potential risks and uncertainties set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2008 and relate to our business plan, our business strategy, development of our proprietary technology platform and our products, timing of such development, timing and results of clinical trials, level and timing of FDA regulatory clearance or review, market acceptance of our products, protection of our intellectual property, implementation of our strategic, operating and people initiatives, benefits to be derived from personnel and directors, ability to commercialize our products, our a
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vincent W. Renz Joins NewCardio as President
2. NewCardio Announces Positive Results From Third Clinical Validation Study
3. Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts
4. Evalve Expands Executive Leadership Team
5. BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
6. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
7. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
8. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
9. RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009
10. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
11. Results From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  Blueprint Medicines ... discover, develop and commercialize novel drug candidates for ... cause of a rare genetic disease. Blueprint Medicines ... identify and optimize drug candidates and will conduct ... an Investigational New Drug (IND) application with the ...
(Date:3/3/2015)... Surgical Company (NASDAQ: STAA ) a leading developer, ... the eye, has named Caren Mason President and ... to STAAR,s Board of Directors in June 2014, and was ... Committee in September 2014, replaces Barry G. Caldwell ... Ms. Mason joins STAAR after most recently serving as CEO ...
(Date:3/3/2015)... 2015 Although lung cancer is the third ... only 18 drugs in the market for its treatment. ... nearing their patent expiry in 2015 and 2017 respectively. ... potential that drug manufacturers are vying to tap into. ... lung cancer (SCLC) and non-small cell lung cancer (NSCLC) ...
Breaking Medicine Technology:Blueprint Medicines Announces Strategic Collaboration with Alexion to Advance Kinase Drug Candidates in Rare Genetic Disease 2Caren Mason Appointed President & CEO of STAAR Surgical Company 2Caren Mason Appointed President & CEO of STAAR Surgical Company 3Caren Mason Appointed President & CEO of STAAR Surgical Company 4Caren Mason Appointed President & CEO of STAAR Surgical Company 5Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3
... Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) today announced ... JMP Securities Tenth Annual Research Conference on ... the Ritz-Carlton in San Francisco. Bank of America Merrill ... at 9:50 a.m. Pacific Time at Encore at Wynn Las ...
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ), ... extracellular matrix , today announced it plans to ... 6, 2011 before the open of the financial markets. ... with the investment community at 8:00 a.m. PDT (11:00 ...
Cached Medicine Technology:Optimer Pharmaceuticals to Present at May 2011 Investor Conferences 2Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6 2
(Date:3/3/2015)... (PRWEB) March 03, 2015 Using an ... schizophrenia to Medicare Part D prescription drug coverage plans ... annually, a new University of Pittsburgh Graduate School of ... reported in the March issue of the journal Health ... Medicare could have saved more than $5 billion in ...
(Date:3/3/2015)... March 03, 2015 Chicago has long been ... icon, Michael Jordan, brought a level of basketball to Chicago ... to experience again since his Chicago Bulls days in the ... exists to this day. This era also witnessed the birth ... brand. Due to this rich basketball culture, US Sports Camps ...
(Date:3/3/2015)... Nutritional supplement e-tailer PureFormulas has been ... the third ecommerce Conference and Expo, to be ... March 10-12. , PureFormulas CMO Daniel Moure will ... (Melbourne time). His session, entitled “Tapping into People’s ... customer’s experience unique via personalization, as well as ...
(Date:3/3/2015)... United Benefit Advisors (UBA), the nation’s leading ... The Gehring Group, Inc. as its newest Partner Firm. ... 20 years, The Gehring Group is a highly respected, ... firm that serves organizations in the design and implementation ... , Based in Palm Beach Gardens, Florida, and ...
(Date:3/3/2015)... OR (PRWEB) March 03, 2015 A ... severity* confirms what water advocate and radio host Sharon ... dehydration – lack of sufficient water in the body ... much as 90 percent of the US population. Kleyne ... is a factor in nearly all disease, including aging ...
Breaking Medicine News(10 mins):Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:US Sports Camps and Nike Basketball Camps Add Five New Locations In and Around Chicago for the Summer of 2015 2Health News:South Florida-based PureFormulas will discuss personalization at ecommerce Conference and Expo in Melbourne, Australia 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 3Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 3
... New York University School of Medicine has been honored ... (AAAS) "for his extraordinary leadership to increase the numbers ... workforce.", Dr. Oppenheimwho serves as the Senior ... at New York University School of Medicinewill receive the ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, Feb. 16 ... state-of-the-nation,s health report and the news is mixed, with life ... On the positive side, life expectancy was up slightly ... beginning of the decade. And while women are still ...
... Division of Breast Oncology at the John Theurer Cancer ... Eighth Annual Northern New Jersey Breast Cancer Conference on ... This free continuing medical education (CME) event will ... Cancer Symposium, an international scientific symposium for breast cancer ...
... When doctors discover high concentrations of regulatory T cells in ... grim, though why exactly has long been unclear. ... School of Medicine suggests these regulatory T cells, whose job ... protein that appears to hasten and intensify the spread of ...
... INDIANAPOLIS Researchers from Indiana University-Purdue University Indianapolis (U.S.A) ... in the February 15, 2011, issue of PLoS ... breaks in their DNA, known as Break-induced Replication (BIR), ... genetic mutation than normal cell repair. Accurate transmission ...
... article published in a forthcoming issue of the Journal ... provide evidence of the effectiveness of exposure therapy with ... disorder (PTSD). The study shows that virtual reality exposure ... an average of seven treatment sessions. Additionally, 62 % ...
Cached Medicine News:Health News:2010 AAAS Lifetime Mentor Award goes to Dr. Joel D. Oppenheim of New York University School of Medicine 2Health News:2010 AAAS Lifetime Mentor Award goes to Dr. Joel D. Oppenheim of New York University School of Medicine 3Health News:2010 AAAS Lifetime Mentor Award goes to Dr. Joel D. Oppenheim of New York University School of Medicine 4Health News:America's Health a Mixed Bag: Report 2Health News:America's Health a Mixed Bag: Report 3Health News:John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference 2Health News:Key culprit identified in breast cancer metastasis 2Health News:Method of DNA repair linked to higher likelihood of genetic mutation 2Health News:Innovative virtual reality exposure therapy shows promise for returning troops 2
... Patient Isolation Drape features less aggressive ... aggressive adhesive strip for easy removal, ... clear, strong poly film, and product ... in a box of 5 or ...
... bed side and near patient testing is ... growth has posed unique problems for hospitals ... quality responsibility to decentralized areas focused on ... the problem is the reality of controlling ...
... The GenoSensor System includes genomic ... software, and reagents. By utilizing ... (CGH) technology for multi-target assessment, ... analyze multiple genomic targets in ...
... The CELL-DYN 3700 combines optical light ... Polarized Scatter Separation (MAPSS) to fully ... to improve performance and productivity in ... the revolutionary concept of complementary technologies ...
Medicine Products: